Luo Fang

2.5k total citations · 1 hit paper
83 papers, 1.7k citations indexed

About

Luo Fang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luo Fang has authored 83 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 28 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luo Fang's work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). Luo Fang is often cited by papers focused on Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (5 papers). Luo Fang collaborates with scholars based in China, United States and Poland. Luo Fang's co-authors include Ping Huang, Qikai Wu, Jun Chen, Fengjuan Chen, Lin Xu, Yingxia Liu, Zhaoqin Wang, Xiaohui Liu, Tao Wang and Lei Liu and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Diabetes Care.

In The Last Decade

Luo Fang

78 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China

2020 483 citations Qingxian Cai, Fengjuan Chen et al. Diabetes Care profile →

Peers

Countries citing papers authored by Luo Fang

Since Specialization

Citations

This map shows the geographic impact of Luo Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luo Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luo Fang more than expected).

Fields of papers citing papers by Luo Fang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luo Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luo Fang. The network helps show where Luo Fang may publish in the future.

Co-authorship network of co-authors of Luo Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Luo Fang. A scholar is included among the top collaborators of Luo Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luo Fang. Luo Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MAFF alleviates hepatic ischemia–reperfusion injury by regulating the CLCF1/STAT3 signaling pathway 2025 ·Cellular & Molecular Biology Letters ·(unknown), Yihua Wang, Shanshan Li, (unknown), Yunhai Luo, Ping Yan, Luo Fang, Zuotian Huang, Zhongjun Wu	2
2	Cost-effectiveness analysis of rezvilutamide versus bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer 2024 ·BMJ Open ·Haiying Ding, Shujing Li, (unknown), (unknown), (unknown), Wenxiu Xin, Zha‐Jun Zhan, Luo Fang	0
3	Ethnic disparities and temporal trends in health resource allocation: a retrospective decadal analysis in Sichuan, a multi-ethnic Province of Southwest China (2009–2019) 2024 ·BMC Health Services Research ·Luo Fang, (unknown), (unknown), Qingqing Fan, (unknown)	2
4	ADCdb: the database of antibody–drug conjugates 2023 ·Nucleic Acids Research ·(unknown), Xiuna Sun, Zhen Chen, (unknown), (unknown), Yi Song, Wenxiu Xin, Haiying Ding, Xinyue Ma, (unknown), (unknown), Jinxin Che, Lili Tan, (unknown), Siqi Chen, Xiaowu Dong, Luo Fang, Feng Zhu	41
5	Caffeic acid phenethyl ester suppresses metastasis of breast cancer cells by inactivating FGFR1 via MD2 2023 ·PLoS ONE ·Qilu Fang, Wenxiu Xin, (unknown), Yuxuan Fu, (unknown), Haiying Ding, Luo Fang	5
6	Association between post-stroke cognitive impairment and gut microbiota: A PRISMA-compliant systematic review and meta-analysis 2023 ·Medicine ·(unknown), (unknown), Luo Fang, (unknown)	5
7	Qingjie Huagong decoction inhibits pancreatic acinar cell pyroptosis by regulating circHipk3/miR-193a-5p/NLRP3 pathway 2023 ·Phytomedicine ·(unknown), (unknown), Luo Fang, Xiaodong Zhu, (unknown), (unknown), (unknown), Guozhong Chen, (unknown)	10
8	Rheum palmatum L. and Salvia miltiorrhiza Bge. Alleviates Acute Pancreatitis by Regulating Th17 Cell Differentiation: An Integrated Network Pharmacology Analysis, Molecular Dynamics Simulation and Experimental Validation 2023 ·Chinese Journal of Integrative Medicine ·(unknown), Luo Fang, (unknown), Kai Li, (unknown), Hui Li, (unknown), (unknown), Guozhong Chen	3
9	Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis 2021 ·PLoS ONE ·(unknown), Lin Tong, Peng Gao, Yan Hu, Huijuan Wang, Zhimin Chen, Luo Fang	12
10	Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China breakdown → 2020 ·Diabetes Care ·Qingxian Cai, Fengjuan Chen, Tao Wang, Luo Fang, Xiaohui Liu, Qikai Wu, Qing He, Zhaoqin Wang, Yingxia Liu, Lei Liu, Jun Chen, Lin Xu	483
11	Cell-Cycle and DNA-Damage Response Pathway Is Involved in Leptomeningeal Metastasis of Non–Small Cell Lung Cancer 2017 ·Clinical Cancer Research ·Yun Fan, Xuehua Zhu, Yan Xu, Xuesong Lu, Yanjun Xu, Mengzhao Wang, Haiyan Xu, (unknown), Xin Ye, Luo Fang, Zhiyu Huang, Lei Gong, Hongyang Lu, Weimin Mao, Min Hu	45
12	OA08.01 Exploration of the Underlying Mechanisms of Leptomeningeal Metastasis in NSCLC Patients through NGS of Cerebrospinal Fluid 2017 ·Journal of Thoracic Oncology ·Yun Fan, Min Hu, Xuehua Zhu, Mengzhao Wang, Yanjun Xu, (unknown), Haiyan Xu, (unknown), Xin Ye, Luo Fang, Zhiyu Huang, (unknown), Lei Gong, Weimin Mao, Hongyang Lu	3
13	Pharmacokinetically guided algorithm of 5-fluorouracil dosing, a reliable strategy of precision chemotherapy for solid tumors: a meta-analysis 2016 ·Scientific Reports ·Luo Fang, Wenxiu Xin, Haiying Ding, Yiwen Zhang, Like Zhong, Hong Luo, Jingjing Li, Yunshan Yang, Ping Huang	17
14	A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration 2016 ·European Journal of Pharmaceutical Sciences ·Xiuling Xu, Jingjing Li, Shunping Han, (unknown), Luo Fang, Yue Sun, Jiazhen Zhu, (unknown), Fanzhu Li	86
15	Preoperative exercise facilitates abundant bone marrow collection in patients with type 2 diabetes for mononuclear cell therapy 2015 ·Cytotherapy ·Zhixian Wu, Luo Fang, Zhifen Wu, (unknown), Xuelian Zou, Ming Jen Tan	2
16	Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial 2013 ·Cytotherapy ·Zhixian Wu, Jinquan Cai, Jin Chen, Lianghu Huang, Weizhen Wu, Luo Fang, Chenguang Wu, Lianming Liao, Ming Jen Tan	28
17	Analysis of Clinical Trials of Drugs Registered in ChiCTR 2012 ·Zhongguo yaofang ·Luo Fang	1
18	Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas 2011 ·Acta Pharmacologica Sinica ·Yun Fan, Nengming Lin, (unknown), Luo Fang, Zhiyu Huang, Haifeng Yu, (unknown)	16
19	Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer 2010 ·Acta Pharmacologica Sinica ·Yun Fan, Nengming Lin, Shenglin Ma, (unknown), Luo Fang, Zhiyu Huang, Haifeng Yu, (unknown)	8
20	Pharmacokinetics study of gemcitabine and its metabolite in Chinese patients with malignant tumor 2005 ·Zhōnghuá yàoxué zázhì ·Luo Fang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact